Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Osheroff

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Biochemistry|July 14, 1987
Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active formN Osheroff, E L Zechiedrich
Progress in Nucleic Acid Research and Molecular Biology|March 4, 2000
Topoisomerase II as a target for anticancer drugs: when enzymes stop being niceJ M Fortune, N Osheroff
Chemical Research in Toxicology|September 1, 1993
When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugsA H Corbett, N Osheroff
Biochemistry|October 16, 1990
Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediateK C Gale, N Osheroff
The Journal of Biological Chemistry|July 11, 1998
Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanismP S Kingma, N Osheroff
The Journal of Biological Chemistry|June 15, 1992
Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II. Potential roles in recombinationK C Gale, N Osheroff
Biochemistry|July 11, 2001
DNA cleavage and religation by human topoisomerase II alpha at high temperatureK D Bromberg, N Osheroff
Current Medicinal Chemistry. Anti-Cancer Agents|August 17, 2005
Etoposide, topoisomerase II and cancerE L Baldwin, N Osheroff
Biochemistry|February 19, 1991
Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIM J Robinson, N Osheroff
Biochimica Et Biophysica Acta|September 28, 1998
The response of eukaryotic topoisomerases to DNA damageP S Kingma, N Osheroff
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Biochemistry|July 14, 1987
Calcium-promoted DNA cleavage by eukaryotic topoisomerase II: trapping the covalent enzyme-DNA complex in an active formN Osheroff, E L Zechiedrich
Progress in Nucleic Acid Research and Molecular Biology|March 4, 2000
Topoisomerase II as a target for anticancer drugs: when enzymes stop being niceJ M Fortune, N Osheroff
Chemical Research in Toxicology|September 1, 1993
When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugsA H Corbett, N Osheroff
Biochemistry|October 16, 1990
Uncoupling the DNA cleavage and religation activities of topoisomerase II with a single-stranded nucleic acid substrate: evidence for an active enzyme-cleaved DNA intermediateK C Gale, N Osheroff
The Journal of Biological Chemistry|July 11, 1998
Topoisomerase II-mediated DNA cleavage and religation in the absence of base pairing. Abasic lesions as a tool to dissect enzyme mechanismP S Kingma, N Osheroff
The Journal of Biological Chemistry|June 15, 1992
Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II. Potential roles in recombinationK C Gale, N Osheroff
Biochemistry|July 11, 2001
DNA cleavage and religation by human topoisomerase II alpha at high temperatureK D Bromberg, N Osheroff
Current Medicinal Chemistry. Anti-Cancer Agents|August 17, 2005
Etoposide, topoisomerase II and cancerE L Baldwin, N Osheroff
Biochemistry|February 19, 1991
Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase IIM J Robinson, N Osheroff
Biochimica Et Biophysica Acta|September 28, 1998
The response of eukaryotic topoisomerases to DNA damageP S Kingma, N Osheroff
Pageof 11